Integer (NYSE:ITGR) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

Integer Holdings Corporation (NYSE:ITGR)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $85.47 and traded as high as $94.40. Integer shares last traded at $93.0490, with a volume of 261,890 shares changing hands.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ITGR. Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Zacks Research downgraded shares of Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Citigroup increased their target price on shares of Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a report on Thursday, May 28th. Finally, Piper Sandler reissued an “overweight” rating and issued a $97.00 price target (up from $87.00) on shares of Integer in a research report on Friday, May 1st. Four investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Integer currently has an average rating of “Hold” and a consensus price target of $98.71.

Integer Stock Up 0.9%

The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77. The company has a market cap of $3.19 billion, a price-to-earnings ratio of 23.44, a PEG ratio of 2.22 and a beta of 0.66. The firm’s fifty day simple moving average is $89.31 and its 200 day simple moving average is $85.53.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The firm had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. Integer’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Sell-side analysts predict that Integer Holdings Corporation will post 6.04 earnings per share for the current year.

Institutional Trading of Integer

A number of institutional investors have recently bought and sold shares of the business. Defilade Capital Management L.P. acquired a new position in shares of Integer during the 1st quarter worth about $18,746,000. Glenmede Trust Co. NA raised its position in shares of Integer by 3.6% during the 1st quarter. Glenmede Trust Co. NA now owns 4,805 shares of the medical equipment provider’s stock worth $423,000 after acquiring an additional 166 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Integer by 408.8% during the first quarter. Janus Henderson Group PLC now owns 83,387 shares of the medical equipment provider’s stock worth $7,339,000 after purchasing an additional 66,999 shares during the last quarter. ADAR1 Capital Management LLC acquired a new position in Integer in the first quarter valued at approximately $770,000. Finally, EverSource Wealth Advisors LLC increased its stake in Integer by 48.1% in the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 117 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.